Amberstone Biosciences
Amberstone Biosciences Inc. discovers transformative immunotherapeutics, focusing on tumor‑activated T‑MATE™ technology to develop precise, safe cancer treatments. The company pioneers next‑gen immunotherapies that trigger immune responses only in tumors, minimizing harm to healthy tissue. Their pipeline spans innovative antibody‑drug conjugates and novel biologics aimed at solid tumors, leveraging proprietary platforms to unlock therapeutic potential previously deemed undruggable.
Amberstone Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Immunotherapy, Cancer, and Therapeutics.
Amberstone Biosciences’ developer surface includes documentation and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 2
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.